Planned safety analysis of a breast cancer prevention study … – EurekAlert (press release)

Prevention — By on December 13, 2008 at 4:07 pm
Planned safety analysis of a breast cancer prevention study
EurekAlert (press release), DC – 8 hours ago
San Antonio – An interim analysis of a breast cancer prevention study using exemestane (Aromasin®) finds an "acceptable" level of bone loss.

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback